Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Anemia × Gemcitabine × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Pancreatic Neoplasms 41 Urinary Bladder Neoplasms 18 Carcinoma, Non-Small-Cell Lung 15 Ovarian Neoplasms 11 Neoplasm Metastasis 11 Triple Negative Breast Neoplasms 10 Nasopharyngeal Carcinoma 10 Breast Neoplasms 9 Lymphoma, Large B-Cell, Diffuse 8 Lung Neoplasms 8 Fallopian Tube Neoplasms 8 Carcinoma, Transitional Cell 7 Neoplasms 6 Cholangiocarcinoma 6 Biliary Tract Neoplasms 6 Recurrence 5 Non-Muscle Invasive Bladder Neoplasms 5 Gallbladder Neoplasms 5 Colorectal Neoplasms 5 Urothelial Cancer 3 Urethral Neoplasms 3 Stomach Neoplasms 3 Melanoma 3 Colonic Neoplasms 3 Carcinoma 3 Ureteral Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Nasopharyngeal Neoplasms 2

Interventions

luspatercept 1 ibrutinib 1 fludarabine phosphate 1 Taxes 1 Rituximab 1 Pharmacogenomic Testing 1 Lenalidomide 1 Gemcitabine 1 Epoetin Alfa 1 Cyclophosphamide 1 CT-P10 1 Biopsy 1 Ascorbic Acid 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06018883 2025-08-07

PTCA199-3

Fudan University

Phase 3 Active not recruiting

Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡